Safety and Tolerability of PRO-185
NCT05470868
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperemia Eye
Interventions
DRUG:
Naphazoline / Hypromellose Ophthalmic
Sponsor
Laboratorios Sophia S.A de C.V.